Alpha DNA Investment Management LLC Acquires New Position in Doximity, Inc. (NASDAQ:DOCS)

Alpha DNA Investment Management LLC bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 9,410 shares of the company's stock, valued at approximately $502,000.

Several other large investors have also bought and sold shares of DOCS. Shaker Investments LLC OH bought a new position in Doximity during the 4th quarter valued at approximately $559,000. Principal Financial Group Inc. raised its stake in shares of Doximity by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company's stock worth $15,695,000 after buying an additional 4,282 shares during the period. Newbridge Financial Services Group Inc. purchased a new stake in shares of Doximity in the fourth quarter worth $362,000. Stratos Wealth Partners LTD. purchased a new stake in Doximity in the 4th quarter worth $203,000. Finally, Wells Fargo & Company MN raised its position in shares of Doximity by 3.3% during the fourth quarter. Wells Fargo & Company MN now owns 368,941 shares of the company's stock valued at $19,698,000 after buying an additional 11,811 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Doximity Stock Performance

Shares of NASDAQ DOCS traded up $2.07 during mid-day trading on Wednesday, reaching $54.47. The company's stock had a trading volume of 1,302,461 shares, compared to its average volume of 1,984,102. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $85.21. The stock has a market capitalization of $10.17 billion, a P/E ratio of 54.47, a P/E/G ratio of 4.10 and a beta of 1.41. The stock has a 50-day moving average of $62.00 and a two-hundred day moving average of $55.94.

Insider Buying and Selling at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 37.40% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research firms have recently commented on DOCS. Raymond James reiterated an "outperform" rating and set a $83.00 target price (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. KeyCorp lowered their price objective on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Leerink Partnrs upgraded shares of Doximity from a "hold" rating to a "strong-buy" rating in a report on Friday, February 7th. The Goldman Sachs Group lifted their target price on shares of Doximity from $58.00 to $80.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Finally, Bank of America raised their price target on shares of Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $65.00.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.